Effects of Body Weight Change in the Medical Supplement Group in Patients with Early Breast Cancer During Chemotherapy: a Randomized, Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this RCT is to compare percent weight change in early breast cancer who takes medical supplement or not, during treatment with chemotherapy (standard AC regimen). The main question is • the change of weight (%) before and after complete treatment of breast cancer therapy. Participants will be randomized into 2 group * intervention group - receive medical supplement daily during chemotherapy treatment. * control group - Nutritional advise during chemotherapy treatment.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:

• Histopathological confirmed diagnosis of breast cancer

• Breast cancer stage I-III

• Recieve adjuvant or neoadjuvant doxorubicin and cyclophosphamide at Rajavithi hospital

• LVEF \>= 60% - ECOG score 0-1

Locations
Other Locations
Thailand
Rajavithi hospital
RECRUITING
Ratchathewi
Contact Information
Primary
Meitinarth Juntong
juntong.mei@gmail.com
+66654415447
Time Frame
Start Date: 2023-07-12
Estimated Completion Date: 2024-12-30
Participants
Target number of participants: 40
Treatments
No_intervention: Control
Nutritional advise
Experimental: Intervention
Medical supplement and nutritional advise
Related Therapeutic Areas
Sponsors
Leads: Department of Medical Services Ministry of Public Health of Thailand

This content was sourced from clinicaltrials.gov